leisure time -WSS

leisure time

author：explore 2025-09-28 13:26:13 - browse：26

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Biogen’s boardroom scandal saddles CEO with first crisis

focus

hotspot

WSS

Montana youths win climate lawsuit against state for promoting fossil fuels

Judge sides with young activists in first

Judge sides with young activists in first

Indictment alleges Trump's ex

Megan Rapinoe shares emotional post following US Women's World Cup exit

Biden administration begins canceling student loan debt for 804,000 borrowers

entertainment

leisure time

focus

How one medical school became remarkably diverse

Judge sides with young activists in first

In age of alternative facts, a scholarly course on calling out crap

Mark Cuban is blaming the wrong people for high drug costs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Health AI: on the border between health care and tech

Duchenne breakthrough therapy leaves behind pioneering families

Mark Cuban is blaming the wrong people for high drug costs

Jerome Adams on the need for new antivirals for Covid

Indictment alleges Trump's ex

entertainment

Indictment alleges Trump's ex

Schizophrenia gene found to be linked to cells' energy dysfunction

Biogen’s boardroom scandal saddles CEO with first crisis

Timeline: How the deadly wildfires took over Maui day by day

BMS, looking to build heart drug business, turns to AI for diagnosis

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

focus

hotspot

hotspot

explore